Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Lolli
Francesco
F
Rovero
Paolo
P
Chelli
Mario
M
Papini
Anna Maria
AM
D000918:Antibody Specificity / Q000276:immunology; D001323:Autoantibodies / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D001665:Binding Sites / Q000276:immunology; D006020:Glycopeptides / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein; D015854:Up-Regulation / Q000276:immunology
D001323:Autoantibodies; D006020:Glycopeptides; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein